Aplidin activates p27Kip1, which is upstream and negatively regulates the activity of the cell cycle inhibitors RAC1/2 [63]; RAC1 inhibitors are emerging as an interesting bullet to treat various forms of cancer [64]. Here, RAC1 is linked to cancer.